Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy - Wikidata - awgldk - TriplyDB

Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy

Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy

http://www.wikidata.org/entity/Q33412571

about

Methods to increase participation in organised screening programs: a systematic review.Management of Precancerous Lesions of the Uterine Cervix according to Demographic Data.Expenditure and resource utilisation for cervical screening in Australia.Prognostic value of HPV E6/E7 mRNA assay in women with negative colposcopy or CIN1 histology result: a follow-up study.Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test Governance of preventive Health Intervention and On time Verification of its Efficiency: the GIOVE Study.Exploiting biospectroscopy as a novel screening tool for cervical cancer: towards a framework to validate its accuracy in a routine clinical setting.Cervical Pap screening among Israeli women, 2005-2010.Excess cervical cancer screening smears: Any benefit? A retrospective cohort in Alsace, France.Impact of HPV vaccination: health gains in the Italian female population.Prevalence of abnormal Pap smears in a consecutive and previously unscreened population in Romania.

P2860

Q30540772-127F7817-F3FC-4A45-88DA-11D861A4FA29 Q33920831-B348A16B-17D1-46F6-805C-5D1B2FDDC4AB Q34502683-05274D65-FEF0-4C17-BD92-581F0B0E7AA1 Q34608714-A6CC19B7-014A-48E7-B644-DC8EA75CE68D Q35140046-7E498555-32C7-4241-B581-3F234385101F Q35838225-14D91FC8-01E6-4E52-A699-8D3120F34060 Q38158188-51CA7E13-419C-4482-9873-C7BDEDAFFAF0 Q39340892-C5959D6A-0C29-4292-91B9-B8B55B65C77A Q39748808-257EDE39-4B8E-482F-90DC-E7D538F0EDA8 Q42368107-2DB1CF56-B6C0-44CF-B515-DDB916153093 Q45734828-1AD28C2E-6CAC-4414-AA8C-C7D91E361ED9

P2860

Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy

http://www.wikidata.org/entity/Q33412571

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy

@ast

Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy

@en

type

label

Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy

@ast

Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy

@en

prefLabel

Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy

@ast

Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy

@en

P1433

Q33412571-B123C2F9-E704-43F1-BFEB-702C0FB568C5

P1476

Q33412571-3827C92F-59DB-4D63-8267-55E4DCEE66DB

P2093

Q33412571-4D10F189-1789-4C8E-926B-3E14C3778353

Q33412571-508ABB84-7221-4924-B9C8-C0E1DB8D1531

Q33412571-A7D93905-DA8D-4095-90EB-E90E4BA39ED5

Q33412571-D4B55483-6649-4B93-AAD8-6D1872C4F17B

Q33412571-E4B5BC36-F1DE-44F8-B903-9DC69AD51335

Q33412571-F62A19EE-6C16-46E9-8B08-F6A35D11F8FD

P2860

Q33412571-09A4279D-E1E0-44E9-B82F-5F93DB4289B3

Q33412571-20E2BB66-7B09-4BCB-B9B6-495A5F5ABA48

Q33412571-2AE8D19F-AB4A-4E34-86AE-B2DBE3073B48

Q33412571-3099315E-B843-4DFF-ADC1-F3637CB362C1

Q33412571-4237FB62-7C87-4F69-A139-4449EE2AFF59

Q33412571-45386776-02EE-40AC-A2D6-02F4EEBBB5DA

Q33412571-4806AA95-B695-451C-B32A-B0F0F9284491

Q33412571-533DB0B7-0610-4D42-BC71-78BF1E5FBA19

Q33412571-6CAA67EE-D67D-42A6-BC97-1E7A2A13BAA2

Q33412571-71E48609-FC20-44B9-AA9E-E7B266DA1257

P2888

Q33412571-F424B3DC-F07A-445F-A098-9781E575CF81

P304

Q33412571-9F1C5A77-0155-4CB8-96D6-DC68F466DAA1

P31

Q33412571-BEFBED58-D077-49D0-BD65-8987679ADFE6

P356

Q33412571-577EB38B-9304-42B9-B271-140747DE637C

P407

Q33412571-35A9432C-6CF5-4A84-B98D-AEB82B9CD897

P478

Q33412571-0F69D8D6-3618-419B-AC7E-A3731F6F617C

P50

Q33412571-7BADFE90-8C13-47C5-B532-5B14C9822CA6

Q33412571-F77D39AA-DD09-4F02-BAE6-6439A6211BF5

P577

Q33412571-A0861AE4-7E34-4328-BA28-C3945B5F5052

P5875

Q33412571-D4D1307F-9AA4-4426-A29B-798517D85769

P6179

Q33412571-B0365AF5-4571-44EE-AE0F-39E9B667F122

P698

Q33412571-65B62FE3-6BAF-4049-A3B9-D5AA72959852

P921

Q33412571-B8C31D12-780D-44E7-BCC7-D2D0100F7798

P932

Q33412571-B6CFCFD0-B248-4FCB-B9CB-DC572E694DA1

P356

P1433

BMC Public Health

P1476

Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy

@en

P2093

Alessandro Ricciardi

http://www.w3.org/2001/XMLSchema#string

Antonio Federici

http://www.w3.org/2001/XMLSchema#string

Fabio Palazzo

http://www.w3.org/2001/XMLSchema#string

Giacomo Furnari

http://www.w3.org/2001/XMLSchema#string

Nathalie Largeron

http://www.w3.org/2001/XMLSchema#string

Sabrina Valle

http://www.w3.org/2001/XMLSchema#string

P2860

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Estimation of Pap-test coverage in an area with an organised screening program: challenges for survey methods

Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics.

Human papillomavirus and cancer: the epidemiological evidence.

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Health and economic implications of HPV vaccination in the United States.

Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.

Economic evaluation of human papillomavirus vaccination in the United Kingdom.

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials.

P2888

P304

71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2458-9-71

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Paolo Giorgi Rossi

Catherine Cohet

P577

2009-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24040870

http://www.w3.org/2001/XMLSchema#string

P6179

1049312240

http://www.w3.org/2001/XMLSchema#string

P698

19243586

http://www.w3.org/2001/XMLSchema#string

P921

P932

2651166

http://www.w3.org/2001/XMLSchema#string